MORE THAN 350 CLINICAL TRIALS COMPLETED
Keystone is internationally recognized as a top ophthalmic clinical research organization. For the past 3 decades, Keystone is a leading investigational site for virtually every participating clinical trial piloting to FDA approval of sight saving ophthalmic drugs and devices. Our vast experience in conducting all phases of clinical trials for devices and pharmaceuticals positions us to be both efficient and effective. These are just a few of the areas we have participated in changing the course of ophthalmology for the better:
GLAUCOMA OR OCULAR HYPERTENSION (HIGH EYE PRESSURE)
Management of glaucoma and ocular hypertension is an ever-evolving science. Thanks to the expertise of our principle investigators partnering with industry leading companies, patients now have an abundance of options in the treatment of their ocular disease. Keystone is committed to continuing to work side by side with pharmaceutical and device companies to help preserve vision for patients world wide.